Lucid Diagnostics (LUCD) EPS (Basic) Growth (3y) (2023 - 2026)
Lucid Diagnostics (LUCD) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 17.98% |
| 10 | Lucid Diagnostics | 176.20 Mn | 142.80 Mn | 55,000.00 | 33.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.18% |
| Mar 31, 2026 | 24.83% |
| Dec 31, 2025 | 27.10% |
| Sep 30, 2025 | 37.52% |
| Jun 30, 2025 | 42.03% |
| Mar 31, 2025 | -14.44% |
| Dec 31, 2024 | 27.83% |
| Sep 30, 2024 | 20.72% |
| Jun 30, 2024 | 19.44% |
| Mar 31, 2024 | -15.84% |
| Dec 31, 2023 | -10.26% |
| Sep 30, 2023 | -33.32% |